denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Novartis
Program: Product Theaters
Hematology Disease Topics & Pathways:
Diseases, Treatment Considerations, Biological therapies, Myeloid Malignancies
Hematology Disease Topics & Pathways:
Diseases, Treatment Considerations, Biological therapies, Myeloid Malignancies
Sunday, December 8, 2024: 11:30 AM-12:30 PM
Room 3
(San Diego Convention Center)
Speakers:
Wolfgang Janke, PhD, Director and Leading Scientist, Novartis Biomedical Research
and
Shruti Kapoor, Novartis Pharmaceuticals Corporation
Disclosures:
No relevant conflicts of interest to declare.
For in-person participants only
See more of: Product Theaters